Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why These Five Stocks Are in Spotlight Today

It’s another calm day on Wall Street as the Dow Jones index is up by just 6 points and the S&P 500 is 0.08% in the red. Among the stocks that traders are talking about for various reasons today are Royal Caribbean Cruises Ltd (NYSE:RCL), Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH), Exxon Mobil Corporation (NYSE:XOM), Chevron Corporation (NYSE:CVX), and Abeona Therapeutics Inc (NASDAQ:ABEO).

In this article, we will examine why each stock is in the spotlight and we will analyze the relevant hedge fund sentiment toward the stocks.

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).

oil, rig, well, gas, oilman, job, russia, fuel, sunrise, power, business, controls, yellow, pump, jack, repairman, male, helmet, orange, drilling, sun, engineer, black, worker,

maradon 333/

Royal Caribbean Cruises Ltd (NYSE:RCL) and Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH) are in the red by around 2% and 5%, respectively, after JPMorgan analyst Joseph Greff downgraded both stocks to ‘Neutral’ from ‘Overweight’. After doing extensive research on sector fundamentals such as GDP growth, spending trends, and capacity changes, Greff came to the conclusion that there will not be a ‘meaningful fundamental turn in net yields/pricing’ in the sector and that the two cruise operators’ earnings could come in below the Street’s expectations. As for Royal Caribbean specifically, Greff thinks the eroding net yields of the company’s China segment as well as the ongoing weakness in Europe will likely hurt results. Greff has a $73 price target on Royal Carribean Cruises, down from the previous $96. The analyst also has lowered its price target on Norwegian Cruise to $44 from $62, as he expects lower demand to also weigh on the company’s quarterly earnings. Of the 749 funds that Insider Monkey tracks, 26 were long Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH) and 39 owned shares of Royal Caribbean Cruises Ltd (NYSE:RCL) at the end of June.

Follow Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH)
Trade (NASDAQ:NCLH) Now!

Follow Royal Caribbean Cruises Ltd (NYSE:RCL)
Trade (NYSE:RCL) Now!

Abeona Therapeutics Inc (NASDAQ:ABEO), a clinical stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, is off by 2.6% after the biotech announced a public offering of 6.0 million shares at $7 a piece. In addition, the company has granted underwriters a 30-day option to buy up to an additional 900,000 shares of common stock. Abeona intends to use the net proceeds of the offering for working capital and general corporate purposes, including for the development of product candidates and general and administrative expenses. According to our records, nine funds owned $14.53 million worth of Abeona Therapeutics Inc (NASDAQ:ABEO)’s stock, which represented 18.90% of the float on June 30, versus seven funds and $15.35 million, respectively, on March 31.

Follow Abeona Therapeutics Inc. (NASDAQ:ABEO)
Trade (NASDAQ:ABEO) Now!

On the next page, we will discuss Exxon Mobil Corporation and Chevron Corporation.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.